IPO registrations (S-1, F-1) · Registrants

NAVIDEA BIOPHARMACEUTICALS, INC.

SEC CIK

810509 · filings on EDGAR ↗

Former names

NEOPROBE CORP (1995–2011)

Registration

Form S-1, first filed 2008-05-05, last 2022-08-02; 6 initial registrations, 8 amendments

Outcome

Final prospectus filed 2022-08-04; declared effective 2008-05-08

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances 2835

Incorporated in

DE

Business address

4995 BRADENTON AVENUE, SUITE 240, Dublin, OH 43017

EIN

31-1080091

EDGAR entity type

operating

Insiders and CEO pay

NAVIDEA BIOPHARMACEUTICALS, INC. on the corporate pages

On this site

• Business registration: NAVIDEA BIOPHARMACEUTICALS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: NAVIDEA BIOPHARMACEUTICALS EXACT (EIN (EXACT))
• Federal award recipient: NAVIDEA BIOPHARMACEUTICALS, INC. Fuzzy (name and state)
• SEC filer: NAVIDEA BIOPHARMACEUTICALS, INC. EXACT (CIK (EXACT))
• Person page: Owen E Johnson MD Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
• Person page: Peter F Drake Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
• Person page: Thomas F Farb Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))

Filings 52

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.